Abstract
Background and Objective: Meclizine (MCZ) is a Biopharmaceutical Classification System (BCS) class-II drug, which is a poorly water-soluble drug along-with very slow-onset of action. In this study MCZ was complexed with different cyclodextrins (CDs), like, sodium sulfobutylether β-CD (SBEβCD), hydroxypropyl β-CD, randomly methylated β-CD, and methyl β-CD, to enhance its solubility for repurposing of this drug for the treatment of infectious diseases and cancer.
Methods: Phase solubility experiments were performed to determine the pattern of MCZ solubilization. Characterization of MCZ-CD complexes were done by Fourier transform infrared (FTIR), X-ray powder diffraction analysis (XRPD) and differential scanning calorimetry (DSC). Results: The FTIR, XRPD and DSC studies clearly revealed the formation of inclusion complexes between MCZ and CDs. Phase solubility results showed that MCZ solubility increased linearly with CD at lower concentration, then get saturated in higher concentration, indicative of an AN type solubility profile. Aqueous solubility of MCZ was enhanced upto 8-16 folds through CD inclusion complexation. Conclusion: These complexation studies confirms the results of molecular modeling in which hydroxy and methyl-substituted CDs revealed the higher inclusion as compared with sulfobutyl substituted CDs.Keywords: Meclizine hydrochloride, phase solubility, cyclodextrins, inclusion complexes, molecular modeling.
Graphical Abstract
Drug Delivery Letters
Title:Cyclodextrin Complexation of Meclizine Hydrochloride and its Influence on the Solubility for its Repurposing
Volume: 7 Issue: 1
Author(s): Mahendra Kumar Hidau, Neelesh Kumar Mehra, Srikanth Kolluru and Srinath Palakurthi
Affiliation:
Keywords: Meclizine hydrochloride, phase solubility, cyclodextrins, inclusion complexes, molecular modeling.
Abstract: Background and Objective: Meclizine (MCZ) is a Biopharmaceutical Classification System (BCS) class-II drug, which is a poorly water-soluble drug along-with very slow-onset of action. In this study MCZ was complexed with different cyclodextrins (CDs), like, sodium sulfobutylether β-CD (SBEβCD), hydroxypropyl β-CD, randomly methylated β-CD, and methyl β-CD, to enhance its solubility for repurposing of this drug for the treatment of infectious diseases and cancer.
Methods: Phase solubility experiments were performed to determine the pattern of MCZ solubilization. Characterization of MCZ-CD complexes were done by Fourier transform infrared (FTIR), X-ray powder diffraction analysis (XRPD) and differential scanning calorimetry (DSC). Results: The FTIR, XRPD and DSC studies clearly revealed the formation of inclusion complexes between MCZ and CDs. Phase solubility results showed that MCZ solubility increased linearly with CD at lower concentration, then get saturated in higher concentration, indicative of an AN type solubility profile. Aqueous solubility of MCZ was enhanced upto 8-16 folds through CD inclusion complexation. Conclusion: These complexation studies confirms the results of molecular modeling in which hydroxy and methyl-substituted CDs revealed the higher inclusion as compared with sulfobutyl substituted CDs.Export Options
About this article
Cite this article as:
Hidau Kumar Mahendra, Mehra Kumar Neelesh, Kolluru Srikanth and Palakurthi Srinath, Cyclodextrin Complexation of Meclizine Hydrochloride and its Influence on the Solubility for its Repurposing, Drug Delivery Letters 2017; 7 (1) . https://dx.doi.org/10.2174/2210303107666170215130631
DOI https://dx.doi.org/10.2174/2210303107666170215130631 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides
Current Radiopharmaceuticals A New Synthesis for Acacetin, Chrysoeriol, Diosmetin, Tricin and Other Hydroxylated Flavones by Modified Baker-Venkataraman Transformation
Letters in Organic Chemistry Tumor Stroma as a Target in Cancer
Current Cancer Drug Targets PPARδ Signaling Regulates Colorectal Cancer
Current Pharmaceutical Design Melanoma Immunotherapy: Past, Present, and Future
Current Pharmaceutical Design Tumor-Specific Delivery of Histidine-Rich Glycoprotein Suppresses Tumor Growth and Metastasis by Anti-angiogenesis and Vessel Normalization
Current Gene Therapy Cytokines, Inflammation and Colon Cancer
Current Cancer Drug Targets Expanding the Therapeutic Potential of Statins by Means of Nanotechnology Enabled Drug Delivery Systems
Current Topics in Medicinal Chemistry Specific Active Immunotherapy of Cancer: Potential and Perspectives
Reviews on Recent Clinical Trials Is Helicobacter pylori Always a "Bad Guy"?
Current Pharmaceutical Design Vitamin D and Breast Cancer Incidence and Outcome
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
Current Cancer Therapy Reviews Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science New Formulation and Evaluation of Camptothecin Encapsulated and/or Dispersed Suppository
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Current Topics in Medicinal Chemistry Modular Protein Engineering in Emerging Cancer Therapies
Current Pharmaceutical Design What is the Current Role of Immunotherapy for Colon Cancer?
Reviews on Recent Clinical Trials Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
CNS & Neurological Disorders - Drug Targets Genetic Polymorphisms of Drug Metabolizing Enzymes and Transporters: The Long Way from Bench to Bedside
Current Topics in Medicinal Chemistry